1 | Carbidopa | [1] Carbidopa Carbidopa | [1] D00558
D00558
| [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [9] 2 2, 4, 6, 13, 17, 90, 140, 164, 201 |
2 | Carbidopa-levodopa | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [3] 2 2, 4, 6 |
3 | Dalfampridine | [1] Dalfampridine Dalfampridine | [1] D04127
D04127
| [4] KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | [2] 4 4, 13 |
4 | Daraprim | [1] Pyrimethamine Pyrimethamine | [1] D00488
D00488
| - | - | [2] 2 2, 4 |
5 | Dexdor | [1] Dexmedetomidine Dexmedetomidine | [2] D00514
D00514
,
D01205
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [4] 2 2, 4, 6, 70 |
6 | DEXMEDETOMIDINE | [1] Dexmedetomidine Dexmedetomidine | [2] D00514
D00514
,
D01205
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [13] 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 212, 215, 226, 280 |
7 | ESKETAMINE | [1] Esketamine Esketamine | [1] D07283
D07283
| [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | [20] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [3] 2 2, 4, 70 |
8 | HB-adMSCs | [1] Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins | - | - | - | [7] 2 2, 4, 6, 13, 46, 49, 113 |
9 | Ketanest | - | - | - | - | [3] 2 2, 4, 70 |
10 | Ketanest-S | - | - | - | - | [3] 2 2, 4, 70 |
11 | Levetiracetam | [1] Levetiracetam Levetiracetam | [1] D00709
D00709
| [1] SV2A SV2A 💬 | [1] ECM-receptor interaction ECM-receptor interaction 💬 | [5] 2 2, 4, 6, 13, 307 |
12 | Levodopa | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [8] 2 2, 4, 6, 17, 90, 140, 164, 201 |
13 | PYRIMETHAMINE | [1] Pyrimethamine Pyrimethamine | [1] D00488
D00488
| - | - | [4] 2 2, 4, 19, 65 |
14 | Stem Cells | - | - | - | - | [4] 2 2, 4, 96, 113 |